Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy
The possibility of detecting genetic mutations rapidly in physiological media through liquid biopsy has attracted the attention within the materials science community. The physical properties of nanoparticles combined with robust transduction methods ensure an improved sensitivity and specificity of...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Beilstein-Institut
2020-01-01
|
Series: | Beilstein Journal of Nanotechnology |
Subjects: | |
Online Access: | https://doi.org/10.3762/bjnano.11.20 |
id |
doaj-36d3acf04d6a48e6ac6ef66ed4630606 |
---|---|
record_format |
Article |
spelling |
doaj-36d3acf04d6a48e6ac6ef66ed46306062020-11-25T02:18:30ZengBeilstein-InstitutBeilstein Journal of Nanotechnology2190-42862020-01-0111126328410.3762/bjnano.11.202190-4286-11-20Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsyMaría Sanromán Iglesias0Marek Grzelczak1Centro de Física de Materiales CSIC-UPV/EHU and Donostia International Physics Center (DIPC), Paseo Manuel de Lardizabal 5, 20018 Donostia-Sebastián, SpainIkerbasque, Basque Foundation for Science, 48013 Bilbao, SpainThe possibility of detecting genetic mutations rapidly in physiological media through liquid biopsy has attracted the attention within the materials science community. The physical properties of nanoparticles combined with robust transduction methods ensure an improved sensitivity and specificity of a given assay and its implementation into point-of-care devices for common use. Covering the last twenty years, this review gives an overview of the state-of-the-art of the research on the use of gold nanoparticles in the development of colorimetric biosensors for the detection of single-nucleotide polymorphism as cancer biomarker. We discuss the main mechanisms of the assays that either are assisted by DNA-based molecular machines or by enzymatic reactions, summarize their performance and provide an outlook towards future developments.https://doi.org/10.3762/bjnano.11.20amplification reactionsbiomarkerscolorimetric biosensinggold nanoparticlesplasmonicssingle-point mutation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
María Sanromán Iglesias Marek Grzelczak |
spellingShingle |
María Sanromán Iglesias Marek Grzelczak Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy Beilstein Journal of Nanotechnology amplification reactions biomarkers colorimetric biosensing gold nanoparticles plasmonics single-point mutation |
author_facet |
María Sanromán Iglesias Marek Grzelczak |
author_sort |
María Sanromán Iglesias |
title |
Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy |
title_short |
Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy |
title_full |
Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy |
title_fullStr |
Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy |
title_full_unstemmed |
Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy |
title_sort |
using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy |
publisher |
Beilstein-Institut |
series |
Beilstein Journal of Nanotechnology |
issn |
2190-4286 |
publishDate |
2020-01-01 |
description |
The possibility of detecting genetic mutations rapidly in physiological media through liquid biopsy has attracted the attention within the materials science community. The physical properties of nanoparticles combined with robust transduction methods ensure an improved sensitivity and specificity of a given assay and its implementation into point-of-care devices for common use. Covering the last twenty years, this review gives an overview of the state-of-the-art of the research on the use of gold nanoparticles in the development of colorimetric biosensors for the detection of single-nucleotide polymorphism as cancer biomarker. We discuss the main mechanisms of the assays that either are assisted by DNA-based molecular machines or by enzymatic reactions, summarize their performance and provide an outlook towards future developments. |
topic |
amplification reactions biomarkers colorimetric biosensing gold nanoparticles plasmonics single-point mutation |
url |
https://doi.org/10.3762/bjnano.11.20 |
work_keys_str_mv |
AT mariasanromaniglesias usinggoldnanoparticlestodetectsinglenucleotidepolymorphismstowardliquidbiopsy AT marekgrzelczak usinggoldnanoparticlestodetectsinglenucleotidepolymorphismstowardliquidbiopsy |
_version_ |
1724881701013815296 |